The Patent Finder

Biogenerix AG

Also on record
Records under this name other than the patents Biogenerix AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Biogenerix AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,207,112Liquid formulation of G-CSF conjugate
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,546,328Liquid Formulation of G-Csf Conjugate
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,222,081Method of Producing and Purifying an Active Soluble Sialyltransferase
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,468,351Erythropoietin solution formulation
Formerly held
Term ended
Term ended Dec 22, 2024 · USPTO record
Term endedTerm ended Dec 22, 2024USPTO record
US 9,050,304Methods of Treatment Using Glycopegylated G-Csf
Formerly held
Lapsed on the fee record
Ended Jun 9, 2023 · Medium confidence
Lapsed on the fee recordEnded Jun 9, 2023Medium confidence
US 9,029,331Glycopegylated Granulocyte Colony Stimulating Factor
Formerly held
Lapsed on the fee record
Ended May 12, 2023 · High confidence
Lapsed on the fee recordEnded May 12, 2023High confidence
US 8,946,161Method of treatment using stable liquid formulation of G-CSF
Formerly held
Lapsed on the fee record
Ended Feb 3, 2023 · USPTO record
Lapsed on the fee recordEnded Feb 3, 2023USPTO record
US 8,703,123Method for obtaining biologically active recombinant human G-CSF
Formerly held
Lapsed on the fee record
Ended Apr 22, 2022 · USPTO record
Lapsed on the fee recordEnded Apr 22, 2022USPTO record
US 8,562,967Stable liquid formulations of G-CSF
Formerly held
Lapsed on the fee record
Ended Oct 22, 2021 · USPTO record
Lapsed on the fee recordEnded Oct 22, 2021USPTO record
US 7,524,655Synthesis of oligosaccharides, glycolipids, and glycoproteins using bacterial glycosyltransferases
Formerly held
Lapsed on the fee record
Ended Apr 28, 2021 · USPTO record
Lapsed on the fee recordEnded Apr 28, 2021USPTO record
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited